TECX insider transaction filings
Tectonic Therapeutic, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-14. Screen TECX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-14 | 4 | McNamara Peter — Chief Scientific Officer | Option exercise (M): 43 @ $14.71 · Sale (S): 43 @ $35 · Option exercise (M): 43 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | McNamara Peter — Chief Scientific Officer | Option exercise (M): 172 @ $14.71 · Sale (S): 172 @ $35 · Option exercise (M): 172 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | REICIN ALISE — Chief Executive Officer, Director | Tax withholding (F): 924 @ $30.34 | EDGAR |
| 2026-06-12 | 4 | Lochner Daniel — Chief Financial Officer | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Chutter Jessica Caroline — Director | Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Vitorovic Stefan — Director | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Tipirneni Praveen P. — Director | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Donenberg Phillip B. — Director | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | SPRINGER TIMOTHY A — Director, 10% owner | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2026-05-06 | 4 | Ruddy Marcella K. — Chief Medical Officer | Sale (S): 1,065 @ $30 | EDGAR |
| 2026-04-03 | 4 | Ruddy Marcella K. — Chief Medical Officer | Sale (S): 1,000 @ $31.05 | EDGAR |
| 2026-04-03 | 4 | Nader Francois — Director | Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Ruddy Marcella K. — Chief Medical Officer | Sale (S): 10,000 @ $30 | EDGAR |
| 2026-03-09 | 4 | McNamara Peter — Chief Scientific Officer | Option exercise (M): 2,500 @ $2.38 · Option exercise (M): 215 @ $14.71 · Sale (S): 6,047 @ $30 · Sale (S): 215 @ $35 · Option exercise (M): 2,500 (derivative) · Option exercise (M): 215 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Ruddy Marcella K. — Chief Medical Officer | Grant/award (A): 26,500 @ $0 · Grant/award (A): 24,250 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | McNamara Peter — Chief Scientific Officer | Sale (S): 1,649 @ $22.06 · Grant/award (A): 23,000 @ $0 · Sale (S): 1,650 @ $25 · Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Schwabish Marc — Chief Business Officer | Grant/award (A): 19,500 @ $0 · Grant/award (A): 17,750 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Lochner Daniel — Chief Financial Officer | Grant/award (A): 26,500 @ $0 · Grant/award (A): 24,250 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | REICIN ALISE — Chief Executive Officer, Director | Grant/award (A): 76,500 @ $0 · Grant/award (A): 69,250 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4/A | REICIN ALISE — Chief Executive Officer, Director | Purchase (P): 2,500 @ $21.10 | EDGAR |
| 2026-02-12 | 4 | Schwabish Marc — Chief Business Officer | Option exercise (M): 4,500 @ $2.38 · Option exercise (M): 4,500 (derivative) | EDGAR |
| 2026-02-12 | 4 | REICIN ALISE — Chief Executive Officer, Director | Purchase (P): 2,500 @ $21.10 | EDGAR |
| 2026-02-11 | 4 | Lochner Daniel — Chief Financial Officer | Purchase (P): 6,000 @ $21.61 | EDGAR |
| 2026-02-10 | 4 | Ruddy Marcella K. — Chief Medical Officer | Tax withholding (F): 2,064 @ $23.22 | EDGAR |
| 2026-02-10 | 4 | McNamara Peter — Chief Scientific Officer | Tax withholding (F): 1,748 @ $23.22 | EDGAR |
| 2026-02-10 | 4 | Schwabish Marc — Chief Business Officer | Tax withholding (F): 1,619 @ $23.22 | EDGAR |
| 2026-02-10 | 4 | Lochner Daniel — Chief Financial Officer | Tax withholding (F): 2,077 @ $23.22 | EDGAR |
| 2026-02-10 | 4 | REICIN ALISE — Chief Executive Officer, Director | Tax withholding (F): 4,104 @ $23.22 | EDGAR |
| 2026-01-05 | 4 | REICIN ALISE — Chief Executive Officer, Director | Option exercise (M): 10,966 @ $2.38 · Option exercise (M): 10,966 (derivative) | EDGAR |
| 2025-12-29 | 4 | McNamara Peter — Chief Scientific Officer | Option exercise (M): 7,000 @ $2.98 · Option exercise (M): 7,000 (derivative) | EDGAR |
| 2025-09-29 | 4 | Ruddy Marcella K. — Chief Medical Officer | Grant/award (A): 5,370 @ $0 · Grant/award (A): 9,750 (derivative) @ $0 | EDGAR |
| 2025-09-29 | 4 | McNamara Peter — Chief Scientific Officer | Grant/award (A): 4,550 @ $0 · Grant/award (A): 8,260 (derivative) @ $0 | EDGAR |
| 2025-09-29 | 4 | Schwabish Marc — Chief Business Officer | Grant/award (A): 4,210 @ $0 · Grant/award (A): 7,650 (derivative) @ $0 | EDGAR |
| 2025-09-29 | 4 | Lochner Daniel — Chief Financial Officer | Grant/award (A): 5,430 @ $0 · Grant/award (A): 9,860 (derivative) @ $0 | EDGAR |
| 2025-09-29 | 4 | REICIN ALISE — Chief Executive Officer, Director | Grant/award (A): 14,700 @ $0 · Grant/award (A): 26,710 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | REICIN ALISE — Chief Executive Officer, Director | Tax withholding (F): 859 @ $19.81 | EDGAR |
| 2025-06-11 | 4 | Vitorovic Stefan — Director | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Tipirneni Praveen P. — Director | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Donenberg Phillip B. — Director | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | MCGUIRE TERRANCE — Director | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | SPRINGER TIMOTHY A — Director, 10% owner | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | SPRINGER TIMOTHY A — Director, 10% owner | Purchase (P): 2,861 @ $14.62 · Purchase (P): 857 @ $15.23 · Purchase (P): 8,092 @ $16.73 · Purchase (P): 9,478 @ $16.31 · Purchase (P): 16,215 @ $14.62 · Purchase (P): 4,856 @ $15.23 · +2 more | EDGAR |
| 2025-04-09 | 4 | SPRINGER TIMOTHY A — Director, 10% owner | Purchase (P): 87,500 @ $17.10 · Purchase (P): 412,500 @ $17.10 | EDGAR |
| 2025-04-07 | 4 | MCGUIRE TERRANCE — Director | Sale (S): 500,000 @ $17.10 | EDGAR |
| 2025-02-07 | 4 | Lochner Daniel — Chief Financial Officer | Purchase (P): 4,617 @ $54.14 | EDGAR |
| 2025-02-07 | 4 | SPRINGER TIMOTHY A — Director, 10% owner | Purchase (P): 129,294 @ $54.14 · Purchase (P): 660,000 @ $50 | EDGAR |
| 2025-02-06 | 4 | Schwabish Marc — Chief Business Officer | Grant/award (A): 14,023 @ $0 · Grant/award (A): 25,496 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | McNamara Peter — Chief Scientific Officer | Grant/award (A): 15,141 @ $0 · Grant/award (A): 27,530 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Lochner Daniel — Chief Financial Officer | Grant/award (A): 18,074 @ $0 · Grant/award (A): 32,862 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Ruddy Marcella K. — Chief Medical Officer | Grant/award (A): 17,876 @ $0 · Grant/award (A): 32,502 (derivative) @ $0 | EDGAR |
Recent 8-K events — Tectonic Therapeutic, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TECX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →